Investor Presentation First Nine Months of 2022

122 Investor presentation First nine months of 2022 GLP-1 market share and market growth in Region China Region China 160% 120% 80% 40% GLP-1 market growth and Novo Nordisk market share 0% Aug 2019 -NN market share -Market growth (right axis) DKK billion GLP-1 market size and growth 160% 117% 120% 80% 71% 1 63% 40% 48% 79.1% 1 ~117% 1 0 3 ~71% 62.5% 0% Aug 2022 Aug 2021 Novo Nordisk Eli Lilly Others Aug 2022 Novo Nordisk Competitors NN share of growth NN growth (right axis) Source: IQVIA, Aug 2022, Value, MAT; NN: Novo Nordisk; Region China covers Mainland China, Taiwan, and Hong Kong

View entire presentation